StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$29.04+0.21 (+0.73%)

Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –

Supernus pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Supernus's pe ratio was 10.6× on Nov 11, 2026, against 33.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.6×−24.9
2025Dec 31, 202535.5×–

More Supernus figures

See a number that looks wrong?